These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7944072)

  • 1. Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome.
    Butterfield JH; Gleich GJ
    Ann Intern Med; 1994 Nov; 121(9):648-53. PubMed ID: 7944072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon treatment for hypereosinophilic syndromes and systemic mastocytosis.
    Butterfield JH
    Acta Haematol; 2005; 114(1):26-40. PubMed ID: 15995323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Isolated mucosal ulcers disclosing idiopathic hypereosinophilic syndrome].
    Billon C; Gautier C; Villaret E; Ducos MH; Martin JC; Geniaux M
    Ann Dermatol Venereol; 1997; 124(3):248-50. PubMed ID: 9686058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypereosinophilic syndromes with prednisone, hydroxyurea, and interferon.
    Butterfield JH
    Immunol Allergy Clin North Am; 2007 Aug; 27(3):493-518. PubMed ID: 17868861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha interferon treatment in idiopathic hypereosinophilic syndrome resistant to conventional therapy].
    Esteve J; Cervantes F; Bosch F; Cobo F; Montserrat E; Rozman C
    Med Clin (Barc); 1996 Mar; 106(8):304-6. PubMed ID: 8667689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Interferon treatment for idiopathic hypereosinophilic syndrome.
    Bockenstedt PL; Santinga JT; Bolling SF
    Am J Hematol; 1994 Mar; 45(3):248-51. PubMed ID: 8296798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective long-term alpha-interferon treatment for hypereosinophilic syndrome.
    Canonica GW; Passalacqua G; Pronzato C; Corbetta L; Bagnasco M
    J Allergy Clin Immunol; 1995 Jul; 96(1):131-3. PubMed ID: 7622756
    [No Abstract]   [Full Text] [Related]  

  • 8. Mucosal ulcerations revealing primitive hypereosinophilic syndrome.
    Barouky R; Bencharif L; Badet F; Salles G; Vital Durand D; Rousset H
    Eur J Dermatol; 2003; 13(2):207-8. PubMed ID: 12695143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy--case report and literature review.
    Baratta L; Afeltra A; Delfino M; De Castro S; Giorgino F; Rossi-Fanelli F
    Angiology; 2002; 53(4):465-70. PubMed ID: 12143954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration.
    Schöffski P; Ganser A; Pascheberg U; Büsche G; Gaede B; Hertenstein B
    Ann Hematol; 2000 Feb; 79(2):95-8. PubMed ID: 10741923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pegylated interferon in hypereosinophilic syndrome.
    Butterfield JH; Weiler CR
    Leuk Res; 2012 Feb; 36(2):192-7. PubMed ID: 22118911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin E levels.
    Acaba L; Mangual A; Vélez García E
    Bol Asoc Med P R; 2000; 92(4-8):59-62. PubMed ID: 11143821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Hypereosinophilic Syndromes.
    Roufosse F
    Immunol Allergy Clin North Am; 2015 Aug; 35(3):561-75. PubMed ID: 26209900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pegylated interferon alpha 2a is an effective and well-tolerated treatment option for lymphocyte-variant hypereosinophilic syndrome.
    Choi C; Moller D; Tan J; Dou C; Peterson EA; Medvedev N; Dutz JP; Carruthers MN; Chen LYC
    Br J Haematol; 2020 Mar; 188(5):e68-e72. PubMed ID: 31721154
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained remission of idiopathic hypereosinophilic syndrome following alpha-interferon therapy.
    Fruehauf S; Fiehn C; Haas R; Doehner H; Hunstein W
    Acta Haematol; 1993; 89(2):91-3. PubMed ID: 8503251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-alpha in the idiopathic hypereosinophilic syndrome: consideration of five cases.
    Ceretelli S; Capochiani E; Petrini M
    Ann Hematol; 1998 Oct; 77(4):161-4. PubMed ID: 9829847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission.
    Quiquandon I; Claisse JF; Capiod JC; Delobel J; Prin L
    Blood; 1995 Apr; 85(8):2284-5. PubMed ID: 7718904
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hypereosinophilic syndromes of myeloproliferative expression with the combination of hydroxyurea and interferon alpha. Apropos of 7 cases].
    Coutant G; Blétry O; Prin L; Hauteville D; de Puyfontaine O; Abgrall JF; Godeau P
    Ann Med Interne (Paris); 1993; 144(4):243-50. PubMed ID: 8368716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete remission of hypereosinophilic syndrome after interferon-alpha therapy: report of a case and literature review.
    Yoon TY; Ahn GB; Chang SH
    J Dermatol; 2000 Feb; 27(2):110-5. PubMed ID: 10721659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa.
    Butterfield JH; Gleich GJ
    J Allergy Clin Immunol; 1994 Dec; 94(6 Pt 2):1318-26. PubMed ID: 7798572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.